PLOD3 and malignant colon neoplasm: Here, we used public databases such as TCGA and GEO to compare the different expressions of PLOD3 and its survival differences in colon cancer to clarify the effect of PLOD3 in the occurrence and development of colon cancer. We confirmed by immunohistochemical analysis that PLOD3 was significantly upregulated in patients with colon cancer.